Here is the latest:
TALLAHASSEE, Fla., Sep 11, 2013 (BUSINESS WIRE) -- Global Green, Inc.
(OTCBB:GOGC) cites an article in last month's
Washington Post that the U.S. Department of Agriculture (USDA) is reviewing
research revealing that new bacteria-killing chemicals used in chicken industry
processing plants may be masking the presence of salmonella and other pathogens
that remain on the birds that consumers buy, causing food illness.
Global Green has developed a patented vaccine to reduce Salmonella in chicken
farming, Salmogenics. It is a safe vaccine that could have significant global
impact against this dreaded infectious disease, without dangerous side effects.
Salmogenics is currently in the final stage of the USDA approval process.
On September 4, the Company announced the signing of an agreement with Merial
Ltd., the Animal Health Division of Sanofi, to conduct an internal evaluation of
Global Green's patented Salmogenics vaccine
technology. At the conclusion of the evaluation, Merial has the first option to
enter into a license agreement with Global Green for the manufacture,
distribution, and sale of the vaccine.
The chemical issue that reportedly currently exists in chicken industry
processing plants came to the department's attention
this spring after chemical companies pointed to academic research that shows
there could be a problem with chicken farming and told the USDA that further
study was needed.
Some experts say the rising tide of chemicals may be causing unanticipated side
effects and endangering food safety. Some USDA inspectors believe such chemicals
can contribute to a host of healthcare and medical problems, including
respiratory ailments and persistent skin rashes.
The World Health Organization (WHO) reports that Salmonellosis is one of the
most common and widely distributed infectious diseases, affecting the healthcare
of tens of millions of people every year. This is a global health issue.
Dr. Mehran Ghazvini, DC, NMD, Chairman and CEO of biotech company Global Green,
Inc., stated "As an infectious disease, Salmonellosis
is responsible for a significant burden of disease in the global health arena
and is notoriously difficult to control in the poultry farm-to-market cycle.
When Salmogenics is used, salmonella contamination is reduced. Not only will
consumers have access to a healthier protein source, but the amount of chemicals
used in the processing plant will be reduced, providing a healthier work
environment for those who work there. This will promote food safety and animal
health."
About Global Green, Inc.
Global Green, Inc. is a green bio-pharmaceutical company committed to
identifying technology platforms and commercializing vaccines that contain
natural organisms that are not genetically modified, utilizing pharmaceutical
standards without the use of mercury. For more information, visit
www.globalgreeninc.com.
